Peptides DB
Research-centric peptide and protocol reference hub
Study 4 of 22PT-141 (Bremelanotide) literatureSemanticScholar2010

Semantic Scholar search for PT-141 (Bremelanotide)

Not reported in abstract.

Read at SemanticScholarAdd to compare

Where it sits

this study against the rest of the pt-141 (bremelanotide) corpus
7
Preclinical · this one
6
Observational
0
Open-label
2
Randomised
7
Reviews

Summary and findings

Not reported in abstract.

How much of this paper we could read: title only (0.00). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2010

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.
  • Not reported in abstract.
  • Not reported in abstract.

Limitations

  • Not reported in abstract.
  • Not reported in abstract.
  • Not reported in abstract.

Elsewhere in the PT-141 (Bremelanotide) corpus

DMultifunctional material platforms for neural interfaces: active orchestration of dynamic foreign body response across implantation lifetimes.Bioactive materials · 2026reviewBAn interpretable machine learning model for predicting febrile seizures following enterovirus infection in children.Annals of medicine · 2026 · n=446 · XGBoost model training set AUC was 0.972 (95% CI: 0.958-0.987).HumanDReal-time sensing-integrated organoid-on-a-chip platforms: Technological progress and emerging biomedical applications.Bioactive materials · 2026reviewDSmart-responsive electrospun scaffolds (SRES) for neural repair: Recent advances and future prospects.Bioactive materials · 2026reviewAHMB supplementation combined with high-intensity functional exercise supports aerobic capacity but not strength in trained and untrained males: a randomized controlled trial.Journal of the International Society of Sports Nutrition · 2026 · n=90 · VO2MAX increased with HMB in TR, p=0.024.HumanDEmerging bioactive microneedle platforms for disease management: From cutaneous disorders to systemic therapeutics.Bioactive materials · 2026review